Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV by Ramirez-Garcia, Pilar & Côté, José
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Health Services Research
Open Access Correspondence
Development of a nursing intervention to facilitate optimal 
antiretroviral-treatment taking among people living with HIV
Pilar Ramirez-Garcia*1 and José Côté2
Address: 1Faculty of Nursing, Université de Montréal, Montréal, Québec, Canada and 2Innovative Nursing Practice, CRCHUM, Faculty of Nursing, 
Université de Montréal, Montréal, Québec, Canada
Email: Pilar Ramirez-Garcia* - pilar.ramirez.garcia@umontreal.ca; José Côté - jose.cote@umontreal.ca
* Corresponding author    
Abstract
Background: Failure by a large portion of PLHIV to take optimally ARV treatment can have
serious repercussions on their health. The absence of a systematic treatment-taking promotion
program in Quebec prompted stakeholders to develop jointly a theory- and evidence-based
nursing intervention to this end. This article describes the results of a collective effort by
researchers, clinicians and PLHIV to share their knowledge and create an appropriate intervention.
Methods: Intervention mapping was used as the framework for developing the intervention. First,
the target population and environmental conditions were analyzed and a literature review
conducted to identify predictors of optimal treatment taking. The predictors to emerge were self-
efficacy and attitudes. Performance objectives were subsequently defined and crossed-referenced
with the predictors to develop a matrix of change objectives. Then, theories of self-efficacy and
persuasion (the predictors to emerge from step 1), together with practical strategies derived from
these theories, were used to design the intervention. Finally, the sequence and content of the
intervention activities were defined and organized, and the documentary material designed.
Results: The intervention involves an intensive, personalized follow-up over four direct-contact
sessions, each lasting 45–75 minutes. Individuals are engaged in a learning process that leads to the
development of skills to motivate themselves to follow the therapeutic plan properly, to overcome
situations that make taking the antiretroviral medication difficult, to cope with side-effects, to relate
to people in their social circle, and to deal with health professionals.
Conclusion: The intervention was validated by various health professionals and pre-tested with
four PLHIV. Preliminary results support the suitability and viability of the intervention. A
randomized trial is currently underway to verify the effectiveness of the intervention in promoting
optimal antiretroviral treatment taking.
Background
The effectiveness of antiretroviral (ARV) treatments in
improving quality of life and life expectancy among peo-
ple living with HIV/AIDS (PLHIV) has been demonstrated
[1-3]. However, positive results are directly related to tak-
ing ARV treatments consistently and optimally, leading to
total long-term viral suppression and, in turn, immuno-
logic recovery [4-7]. Yet, in both clinical follow-ups and
the scientific literature, a significant percentage of PLHIV
have been reported not to persevere with optimal treat-
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ment taking [8,9]. In Quebec, a longitudinal study [10]
showed that at each three-month follow-up 15% to 18%
of participants had not taken their ARV treatment opti-
mally in the past seven days. After one year of follow-up,
only 50% of the participants continued to take the treat-
ments at the optimum level at each time of measurement.
Furthermore, at the first forum organized by COCQ-Sida
(Quebec Coalition Against Aids) in 2004, PLHIV in the
province described the challenges inherent in taking ARV
treatment every day and expressed their need for assist-
ance and support in order to adopt and maintain this
behaviour. Against this backdrop, an intervention to facil-
itate optimal ARV-treatment taking would be of benefit to
PLHIV in the community.
Scientific studies evaluating interventions to optimize
ARV-treatment taking are a recent phenomenon, with
most having been published since 2000 [11-14]. About 20
studies have demonstrated the capacity of certain inter-
ventions to promote treatment-taking behaviour, and five
of these have also observed a clinical effect. Interventions
in these randomized trials were administered to individu-
als with the intent of providing them with medication-
management skills [15]. However, none of these interven-
tions was based on a theoretical framework that provided
a comprehensive understanding of the behaviour
involved in taking an ARV treatment or laid down ways to
foster this behaviour.
In the light of these findings and the fact that no system-
atic intervention existed for PLHIV in Quebec, a theory-
and evidence-based intervention was deemed necessary to
optimize ARV-treatment taking in the community. The
purpose of this article is to document the results of a col-
lective effort by researchers, clinicians and PLHIV to share
and combine their knowledge in the aim of developing
such an intervention.
Methods: intervention mapping
We followed the guidelines proposed by Bartholomew,
Parcel, Kok and Gottlieb [16,17] in a method referred to
as "intervention mapping" (IM), a stepwise approach for
the development and subsequent implementation of
interventions grounded in theory and empirical data. It
provides a framework that affords intervention planners a
systematic mode for integrating theory, research results
and field data collected from the target population at each
phase of intervention development. Although we present
intervention mapping as a series of six steps, the process is
actually iterative and cumulative. Intervention developers
base each step on the previous one, moving back and
forth between tasks and steps as they gain information
and different perspectives from various activities.
Accordingly, researchers must first conduct a needs assess-
ment or problem analysis. This encompasses a review of
the scientific literature to identify the main determinants
of health behaviour as well as an analysis of the target
population and environmental conditions. Second,
researchers create matrices of change objectives based
both on performance objectives and on predictors of opti-
mal behaviour. Third, theoretical foundations must be
defined and underlying theoretical methods and practical
strategies identified. Fourth, researchers must translate
methods and strategies into an organized intervention.
Fifth, researchers must plan the adoption, implementa-
tion and sustainability of the intervention. Finally, an
evaluation plan must be provided for.
Step 1: Needs assessment
To gain a comprehensive understanding of the overall
needs of the community of people on ARV treatment and
to assess the capacity to modify their behaviour in this
regard, we entered into a partnership with COCQ-Sida, a
coalition of community organizations involved in the
struggle against AIDS in Quebec. Our involvement in the
coalition's "Treatment Adherence Committee" enabled us
to collaborate with nurses, social workers, PLHIV and
other stakeholders throughout the course of intervention
development.
Analysis of target population and environmental conditions
The number of PLHIV in Quebec has been estimated at
between 13,300 and 19,600 [18], with about two-thirds
living in the health and social services region of Montreal
[19]. Approximately 83.4% are males of Canadian origin
and the majority has had homosexual relations.
In Quebec, the public healthcare insurance system ensures
universal access to health services and treatment, includ-
ing ARV medication. Clinical follow-up of PLHIV is
ensured by general practitioners in family-medicine clin-
ics and by microbiologists in outpatient clinics. Such fol-
low-up is largely medical and focuses on the clinical facets
of the infection. As well, there are community groups that
provide information on and peer support for HIV and
treatment. However, there is no guidance or systematic
intervention to foster ARV-treatment taking this popula-
tion.
Analysis of behaviour
To promote optimal ARV-treatment taking, it is important
to understand the behaviour and identify the factors asso-
ciated with it. In their review of the literature, Ramirez-
Garcia and Côté [20] found the most significant modifia-
ble factors in this regard to be social support [21,22], atti-
tudes [23], self-efficacy [24,25], frequency of treatment
regimen [26], side-effects [27,28] and degree of satisfac-
tion with health professionals [23,29].
A longitudinal study of 376 PLHIV in the target commu-
nity [10] confirmed the importance of treatment takingBMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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and the influence of the above factors. The best predictive
model included high self-efficacy, positive attitudes
toward taking medication, not living alone and being
male. Secondary analysis demonstrated that, of the above
factors, the ones that could be improved so as to affect
self-efficacy were social support and satisfaction with
healthcare professionals. The same two factors and the
absence of adverse side-effects also influenced attitudes.
Thus, the theoretical framework of Godin et al. [10] was
not only useful in predicting optimal medication-taking
behaviour but also in explaining how such behaviour
could be fostered in PLHIV.
The needs assessment culminated with the definition of
the ultimate objective of the intervention, the desired
behavioural outcome. For this project, it would be opti-
mal ARV-treatment taking among PLHIV in the commu-
nity.
Step 2: Matrix of intervention objectives
Objectives were further specified at this step of IM. First,
the behavioural outcome was broken down into its com-
ponent parts. These components parts were referred to as
a performance objective. For this project, we formulated
five performance objectives: follow treatment plan prop-
erly as part of daily routine, overcome situations that
make taking medication difficult, cope with side-effects,
relate well to those in one's personal social circle, and
interact effectively with health professionals.
Finally, we formulated change objectives. These were the
most immediate goals for the intervention to accomplish
and were stated in terms of exactly what a person needed
to learn to facilitate performing a specific behaviour.
Change objectives were formulated by examining the per-
formance objectives with regards to the predictors of opti-
mal ARV-treatment-taking behaviour. Table 1 presents the
matrix of intervention objectives for two performance
objectives.
Step 3: Theoretical methods and practical strategies
Step 3 in IM consisted in selecting useful theory-based
methods to influence behaviour and the strategies to
organize and operationalize the intervention methods.
Two theories served as the foundation for the develop-
ment of our intervention: Bandura's self-efficacy theory
[30] and Petty and Cacioppo's persuasion theory for atti-
tudinal change [31].
Self-efficacy theory
Bandura defined self-efficacy as an individual's belief in
his or her own ability to organize and implement action
to produce a desired result. He stated that individuals
must have firm confidence in their abilities to undertake
and follow through with the procedures necessary to suc-
ceed. He argued that individuals took action when a sense
of efficacy made the effort seem worthwhile in order to
attain the expected results. He further defined result
expectations as opinions about the probable outcomes
Table 1: Matrix of intervention objectives
Performance objectives Predictors
Self-efficacy Attitudes
PO.1. Overcome situations that make taking 
ARV medication difficult
SE.1a. Identify negative emotions in these 
situations: record and describe negative 
emotions in these situations
A.1a. Anticipate negative consequences of 
negative emotions on behaviour
SE.1b. Express confidence that one can cope 
with one's emotions
A.1b. Expect to avoid and cease negative 
emotions
SE.1c. Use (entertainment or relaxation) 
strategies to avoid and cease negative emotions
A.1c. Argue that negative emotions can be 
avoided or ceased
SE.1d. Identify patterns or situations that make 
taking medication difficult
SE.1e. Express confidence that one can take 
medication in every situation
A.1e. Argue that, in dealing with situations that 
make taking medication difficult, there will be 
fewer omissions
SE.1f. Adopt new tools or strategies to 
overcome difficult situation and take ARV 
medication
A.1f. Expect to deal with situations that make 
taking medication difficult and fewer omissions 
in future
PO.2. Deal with health professionals SE.2a. Identify role of healthcare professionals 
with regard to ARV therapy
SE.2b. Recognize situations that call for advice 
from various health professionals
SE.2c. Express confidence that one can ask for 
advice from various health professionals about 
ARV therapy
A.2c. Consider healthcare professionals as 
health partners or councillors who can provide 
means to take ARV tretament
SE.2d. Correctly use strategies to ask for 
advice from health professionals about ARV-
treatment taking
A.2d. Expect that interacting with various 
health professionals will be beneficial to 
optimizing ARV-medication takingBMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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that actions would lead to and considered an individual's
attitude to be a form of these expectations.
According to Bandura [30], self-efficacy is a productive
characteristic that is crucial to acquiring the skills neces-
sary to adopt a behaviour. It affects cognitive, motiva-
tional and emotional processes, and these can improve or
deter performance. In view of this, skills acquisition in
these areas helps not only establish behaviour considered
necessary but also control the influence of these processes
on learning and on behaviour. Finally, Bandura argued
that self-efficacy was a contributor to the acquisition of
these skills in that it relied on them to promote desired
behaviour. In this intervention, four principal sources
described by Bandura were used to enhance self-efficacy:
sense of mastery, vicarious experiences, verbal persuasion,
and management of physiological and emotional states.
According to self-efficacy theory, "mastery experiences"
are the most influential means of expanding one's efficacy
because they show most clearly how people can bring
together the things they need to succeed. Bandura consid-
ered that mastering difficult tasks afforded people a new
perspective on efficacy by increasing their confidence in
their own capabilities. He regarded problem solving as a
cognitive skill that facilitated learning how to master dif-
ficult tasks. For starters, he believed that the individual
must learn to monitor his or her behaviour to identify
conditions in which the behaviour arose. In his view, self-
observation was a self-regulating motivational skill that
was necessary to be able to set realistic objectives, evaluate
progress and, as a result, nurture a sense of personal effi-
cacy.
With regard to "vicarious experience," Bandura stated that
evaluations of efficacy were partly influenced by the
achievements of others. The more an individual identified
with these others, the more influential their experiences of
success became. He suggested models that taught these
skills could stimulate the personal efficacy of individuals.
As well, individuals could draw a greater benefit from
examples in which difficulties were overcome by persever-
ance rather than from examples of easier tasks carried out
by expert models. For Bandura, a cognitive model or visu-
alization was a vicarious experience that influenced subse-
quent performance. Our intervention incorporated
visualization into the problem-solving process.
Bandura [30] maintained that individuals verbally "per-
suaded" of having the skills to master certain activities
were more likely to make an added effort and sustain it
than self-doubting individuals were. He asserted that such
verbal persuasion, which highlighted personal abilities
and progress, boosted self-efficacy. He saw information
about other peoples' success norms and the attribution of
failure to either ineffective strategies or degree of task dif-
ficulty as persuasion strategies that strengthened the sense
of self-efficacy.
Moreover, Bandura stated that people often interpreted
their physiological and emotional reactions to stressful or
demanding situations as signs of vulnerability or dysfunc-
tion. He believed that the skills to control these emotional
reactions heightened the sense of efficacy, resulting in a
corresponding improvement in performance. Hence, we
included the acquisition of emotional self-management
skills in our intervention.
The theoretical structure of or intervention is presented in
diagram form in Figure 1. The diagram shows the matrix
of relationships between the empirical basis of behaviour,
such as the predictors of ARV-treatment-taking, and the
theoretical basis, which recommends which skills should
be developed to facilitate this behaviour.
Persuasion theory
Under the Elaboration Likelihood Model proposed by
Petty and Cacioppo [31], persuasive communication is
seen as central to bringing about attitudinal change. The
term "elaboration" refers to the extent to which individu-
als receiving a message will devote an effort to pondering
its contents in shaping their attitudes. These authors
describe two courses for processing information: central
and peripheral.
When individuals are motivated and able to think and
understand the message, the model predicts that they will
follow the central course to make up their minds. How-
ever, when an individual is distraught or unmotivated, the
information will be processed peripherally. Petty and
Cacioppo [31] consider attitudes formed or changed via
the central course to be relatively enduring predictors of
behaviour and resistant to change. Consequently, this is
the course that should be favoured for attitude reinforce-
ment or change. To ensure the effectiveness of a persuasive
message, it should therefore be framed in substantive
terms and conveyed when individuals are motivated and
able to concentrate on it.
When individuals are distressed or unmotivated, other
peripheral mechanisms, such as the cognitive-reasoning
process, the affective-conditioning process and social
influence should be applied. Similarly, Petty, Wegener
and Fabrigar [32,33] observed that a simple means of
influencing people's attitudes in either a positive or nega-
tive direction was to ask them to analyze the positive or
negative aspects of the behaviour. This cognitive process is
known as self-persuasion. The authors added that repeat-
edly associating behaviour with positive feelings or with a
stimulus that produced positive feelings (i.e., an affectiveBMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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Theoretical structure of intervention Figure 1
Theoretical structure of intervention.
  Situational and physiological factors  
    Side effects
    Perceived social support 
    Satisfaction with physician
  Predictors
    Attitude
    Self-efficacy
  Behaviour
    Optimal antiretroviral treatment
    taking
Theoretical framework of behaviour 
(Godin &  al., 2005)
Intervention skills
   To follow the treatment plan properly in the daily 
routine: self-monitoring, reward
   To overcome situations that make taking the 
antiretroviral medication difficult: coping 
with negative emotions and problem 
solving process  
   To cope with side effects
   To relate to people in the individual’s social 
circle
   To deal with health professionals
Self-efficacy sources
   Skills mastery
   Vicarious experiences
   Verbal persuasion
   Physiological and emotional 
   states
 Mediator process
  Cognitive
  Emotional
  Motivational 
Self-efficacy theory (Bandura, 1997)  [30]
Attitude reinforcement
  Persuasive communication
  Self-persuasion
  Conditioning
Petty and Cacioppo theory (1986) [31]
Theoretical framework of 
intervention 
Table 2: Theories, methods and strategies regarding targeted predictors of behaviour
Predictors/Theories Methods Strategies
Attitudes
(Petty and Cacioppo, 1986 [31]; Petty, Wheeler and 
Fabrigar, 1997 [33]; Petty, Fabrigar and Wegener, 2003 
[32])
Persuasive communication Tailored information
Explanation/reflection or discussion
Constructive feedback on positive attitudes
Self-persuasion Reflection or discussion
Conditioning Reward after behaviour
Association of positive thoughts
Self-efficacy/skills
(Bandura, 1997) [30]
Direct experience of mastering issues Self-observation of behaviour: recognition of 
success
Problem-solving process
Establishing goals
Application of skills/constructive feedback
Vicarious experiences Modeling: Case history
Self-modeling or visualization
Verbal persuasion Attribution of cause of mistakes to inadequate 
strategies or difficulty of task
Allusive feedback 
(comparison to other groups or norm)
Constructive feedback on acquisition of skills
Physiological and emotional state Demonstration of impact of negative thoughts on 
behaviour
Explanation/reflection or discussion on activating 
emotions
Application of emotion-management skillsBMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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"conditioning" process) could lead to positive attitudes
toward the behaviour. Both of these methods were incor-
porated in our intervention (Table 2).
Step 4: Intervention
At this step, the intervention was designed by translating
the theoretical methods and practical strategies into inter-
vention documents. This intervention drew its inspiration
from a philosophy of empowerment. In this approach,
the PLHIV must be actively involved in seeking the infor-
mation required to foster optimal ARV-treatment taking
behaviour, and the health professional becomes a partner
in care and a counsellor helping the individual develop
the skills to facilitate this behaviour.
The intervention consisted of a customized follow-up of
four 45- to 75-minute sessions with an HIV-expert nurse.
The first three sessions focused on the appropriation and
mobilization of specific skills in a planned order: motiva-
tional skills to follow the therapeutic plan properly and
skills to cope with side-effects, including skills to identify
and manage them (first session); skills for coping with
negative emotions and for problem-solving to deal with
situations that make taking ARV medication difficult (sec-
ond session); skills for relating to people in one's social
circle and for dealing with health professionals (third ses-
sion). The skills thus learned were boosted in the final ses-
sion.
While each session focused on specific skills, it was always
possible to review those discussed previously. Different
tools were utilized to facilitate use of the skills acquired,
such as a chart for observing behaviours and a personal
diary for recording side-effects (developed by the princi-
pal investigator and validated by HIV-expert health pro-
fessionals). The individuals' understanding and use of the
new skills were evaluated and positively reinforced at each
session. As well, at the end of each session, the nurse sug-
gested that the individual set objectives for the next one.
These objectives would guide and motivate the individu-
als to integrate the skills they had learned in their daily
routines and to verify their usefulness [30]. Various docu-
ments were used to assure retention of the new informa-
tion, for example, leaflets on the range of ARV treatments
available [34] and leaflets recommending ways of dealing
with adverse side-effects. Specifically, each meeting was
organized and proceeded as follows.
First session
During the first session the individual was called upon to
develop and reinforce skills that would be useful in taking
ARV medication as part of the daily routine. For starters,
the individual was given personalized explanations on
how the treatments worked, their purpose, the impor-
tance of taking them (strictly following a regular regi-
men), how to take them (with or without food, intervals,
storing the product properly) in addition to tools and
strategies to make taking medication easier (pillbox, clock
radio or alarm). This educational component paved the
way for the development of skills and was tailored to the
individual's needs and level of awareness. This session
was also designed to help develop motivational skills,
such as monitoring and rewarding behaviours. Each of
these was supposed to foster ARV-treatment taking.
One strategy for developing a positive attitude toward tak-
ing ARV medication was to associate each dose with a pos-
itive image or message, such as that of the sea or the sun
or repeating that the medication would preserve good
health longer. Assessing one's own behaviour (self-regu-
lating skills) involved analyzing circumstances and the sit-
uation in which treatment was neglected or forgotten:
"Who was I with? What was I doing?" This process would
lead to finding ways to resolve the problem. Conversely,
the individual analyzed situations in which he or she suc-
cessfully took the medication and gained the incentive to
do so again. Attaching positive significance to treatment
taking would make taking medication repeatedly with a
positive attitude all the easier. The final objective of the
session was to enable individuals to identify and deal with
adverse side-effects of the ARV treatment. With the nurse's
help the side-effects were identified, as were ways of
avoiding or moderating them.
Second session
The second session focused on skills to cope with negative
emotions and resolve problems. As negative attitudes
deter motivation and affect behaviour, they have detri-
mental repercussions on ARV-treatment taking. It was
therefore important to be able to recognize them and keep
them from persisting or intensifying. The most effective
means of managing thoughts and feelings were discussed;
most notably, individuals learned to repeat calming,
encouraging and comforting phrases (positive messages)
to themselves [30]. As well, techniques for self-distraction,
such as reading, watching films and seeking comfort from
companions were reinforced.
The problem-solving process was addressed in the second
part of this session to equip the individual to overcome
difficult or awkward situations. This process, adapted
from Sharma, Petosa and Heaney [35] and from Lorig and
Fries [36], consists in: 1) describing the situation in which
the oversight occurred; 2) elaborating a list of strategies
for dealing with the situation; 3) choosing the strategy
with the highest probability of being useful; 4) imagining
oneself facing up to the situation; 5) deciding to take
action and confronting the situation using this strategy;
and 6) evaluating the results.
The process was presented by means of a case history, in
the aim of facilitating learning through vicarious experi-BMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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ence. It was then put into practice by the individual in a
situation in which he or she found it difficult to take ARV
treatment. A mnemonic technique using the first letter of
each step of the process to spell out "Decide" made it eas-
ier to remember.
Third session
In this session, the focus was on mastering social skills
and the skills for dealing with health professionals in
order to enable individuals to mobilize formal and infor-
mal networks to assist with ARV-medication taking. Here,
the nurse explained a process framed by Bergeron [37]
that entailed identifying people likely to provide support
and then establishing, reinforcing and maintaining rela-
tions with them. Thus, the individual could seek help and
mobilize support.
This session began with an explanation of different types
of social support (emotional, material, informational,
and social integration), their importance and the impact
they had on ARV-treatment taking. Next, the nurse asked
the individual to think about which members of his or her
social circle helped or could help with medication taking.
The nurse then provided details of different community
organizations involved in the struggle against AIDS and
the services they offered. Strategies for creating opportuni-
ties to meet with other people, increase interaction, main-
tain contact and open dialogue with them were then
discussed [38,39]. Two key communications skills – atten-
tive listening and expressing feelings – were explained and
demonstrated with concrete examples from daily life [40].
The nurse then used role playing to simulate seeking aid
or mobilizing social support: This activity involved mak-
ing a request, listening to the other person's reaction and
giving feedback on the response or support received.
In the final portion of this encounter, the nurse explained
the different roles of the health professionals involved
(nurse, physician, pharmacist, dietician, psychologist, and
sexologist) and described situations in which their help
was called for. The nurse then went over the above com-
munication skills again to demonstrate how to deal with
professionals efficiently, which entailed preparing for
meetings, listening carefully when taking in information,
giving and receiving feedback, and obtaining responses to
questions.
Fourth session
A final booster session was held to reinforce the skills that
had been imparted. The nurse assessed whether the objec-
tives had been attained and offered the individual the
opportunity to work further on the skills covered in previ-
ous sessions.
Details of the intervention and copies of intervention
materials are available on request.
Step 5: Implementation
At this stage, it was important to ensure that the project
met the needs of the target community, could be imple-
mented and could obtain the necessary support of part-
ners and decision-makers. The fact that this was the first
time a systematic intervention to help with ARV-treatment
taking had been offered had to be taken into considera-
tion in planning how to implement it. It was important
therefore to find out to what extent our designed interven-
tion met the needs of PLHIV and was accepted by them.
To this end, the content of the intervention and the docu-
mentation prepared for the participants were validated by
HIV health experts: two nurses, two dieticians, a physician
and a pharmacist. They used a four-point Likert-type scale
to evaluate the accuracy, clarity, relevance, and impor-
tance of the information provided in the intervention and
the documentation to be given to the participants. They
also expressed opinions on the relevance, importance, fea-
sibility, and acceptability of the intervention and were
asked to include explanations or justifications whenever
they rated items on the scale as having little or no rele-
vance, importance, accuracy, or clarity (i.e., 1 or 2) or
when they had other observations about the intervention.
Generally speaking, these professionals gave the perti-
nence of the information provided in both the interven-
tion and the documentation a rating of 3 or 4.
Information on CD4 count and viral load, the importance
of taking medication appropriately and getting around
side-effects received a rating of 2 for its precision and clar-
ity. Accordingly, we re-formulated this material with the
aid of the professionals' comments (some examples are
given in Table 3).
Furthermore, both the documentation and the interven-
tion were pre-tested with four HIV-positive individuals,
three men and one woman, on ARV medication. This was
done to ensure that the intervention was acceptable and
met the needs of PLHIV and that the language was clear
with difficult and complex terms explained. They used the
same Likert-type scale as the health professionals and pro-
vided comments and criticisms. These PLHIV gave the
importance of the information in the intervention and the
documentation a rating of 3 or 4. The small portion of the
content that was rated 2 has since been modified
(Table 3).
In general, all of the professionals gave the relevance,
importance and suitability of the intervention and its fea-
sibility a rating of 3 or 4. Their consensus was that the
intervention was acceptable and that it was important to
implement an intervention that could both foster ARV-
treatment taking and that was consistent with the nature
of the community. Similarly, the PLHIV expressed their
satisfaction with the intervention and with the new skills
it afforded them.BMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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In order to obtain support for setting it up the interven-
tion, COCQ-Sida assisted in contacting a family medicine
clinic specialized in sexually transmitted diseases (STDs)
and HIV/AIDS in Montréal. A service agreement was
reached with the clinic to make our intervention available
to PLHIV, in exchange for physical space for carrying it
out. To facilitate cooperation with the clinic's profession-
als in identifying and referring participants, a number of
presentations were made on the content of the interven-
tion. A fundamental aspect of this project was its imple-
mentation by the researcher/clinician, who was present
full-time in the clinic to facilitate its integration by the
team of health professionals and to assist with participant
recruitment.
Step 6: Evaluation plan
An experimental design was developed to evaluate the
effects of the intervention. The intensive personalized fol-
low-up over four direct-contact sessions would be com-
pared with usual care. The usual-care intervention was not
systematic. It was performed by the clinic nurse and con-
sisted of a detailed explanation of the prescribed treat-
ment and follow-up at the request of the PLHIV. The
following hypotheses were tested: a greater proportion of
participants receiving the intervention than of those in the
control group would have taken their medication opti-
mally at the T3- and T6-month follow-ups. Self-efficacy,
attitudes, side-effects, social support, and relations with
health professionals were mediator variables correlated
with optimal treatment taking. Optimal treatment taking,
the principal outcome, was evaluated on the basis of a
self-administered questionnaire, viral load and CD4
count. The results of this evaluation will be published
soon.
Discussion
The importance of behaviour and the factors that deter-
mine it in the achievement of optimal ARV-treatment tak-
ing is widely recognized. Few studies, however, have
demonstrated the effectiveness of interventions to pro-
mote optimal medication taking, in part, however, owing
to the poor methodology used [14,15]. There are also gaps
in the information on the development of interventions.
Apparently, they have not always been founded on a solid
theoretical or empirical framework and are largely derived
from components of information. This information con-
tent is clearly essential, but it is not sufficient to facilitate
optimal treatment taking [41].
Nonetheless, the authors of a recent exhaustive review of
the literature [15] did find evidence supporting the effec-
tiveness of some interventions in this regard. In fact, they
were able to identify certain criteria for effectiveness: The
interventions have to target medication-management
Table 3: Validation comments by HIV health experts and PLHIV
Sections/Topic Observations made by HIV health experts
Implications of CD4 count and viral load "To avoid confusion, I suggest always referring to the CD4 count in terms of a decrease, rather than 
saying that CD4 should remain 'above' 350 or that the risk of opportunistic infections 'increases' if it 
falls below 350."
"Explain RNA... For example: each virus has a similar genetic code, which is the virus RNA and which 
is identifiable through laboratory analysis... Each RNA = 1 virus."
"According to DHHS guidelines, treatment is recommended if the CD4 count is between 200 and 
350, regardless of the viral load ... and should be altered if the viral load is >100,000 and particularly if 
the viral load is very high."
Importance of taking medication effectively "More and more people are taking treatment only once a day, so the significance of this should be 
stressed (in terms of missed dosages per month)."
"Add more emphasis and explanation about mutations; for example: some of these errors allow the 
virus to become resistant to treatment... the virus can then multiply increasingly and the viral load 
increases again."
Techniques for contending with side-effects "I advise seeking a consultation if a cutaneous eruption appears right away because there is a lot of 
syphilis around and it presents with a skin rash."
"Add that it is important to consult a dietician when there is weight loss of more than 5% of the 
normal weight."
"Instead of recommending avoiding or cutting out dairy product consumption, you could suggest 
alternatives such as trying lactase."
"Instead of just saying that it is necessary to re-hydrate, be more precise about how to do this: 
prepare and drink pharmacy re-hydration beverages such as Pédialyte® or Gastrolyte® or make their 
own."
Sections/Topic Remarks made by PLHIV
Importance of taking medication effectively "I didn't understand the resistance part, it was difficult to follow; maybe you could add a diagram 
(sketch) to help us understand it."
"I couldn't follow the material on mutations and resistance... It's all too complicated."
Recognizing oversights "I thought I had understood, but when I got home and I wanted to make notes, I didn't know how to 
set about it: there should be more explanations and examples given.
Techniques for solving problems "It's difficult to keep in mind all the steps: a written version of part should be available."BMC Health Services Research 2009, 9:113 http://www.biomedcentral.com/1472-6963/9/113
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skills and must be administered to individuals rather than
to groups, and the duration of the intervention has to be
at least 12 weeks. Results of other randomized trials car-
ried out since the literature review in question also sup-
port these conclusions [42-44].
These findings justify our efforts to develop a solid theory-
based nursing intervention that enables us to explain and
predict behaviour that fosters optimal ARV-treatment tak-
ing. Using a systematic approach that allowed the integra-
tion of a theoretical framework, we structured our
intervention on the basis of empirical and clinical data.
This interweaving of different knowledge sources is an
obvious strength of the mapping approach: It allows the
proficiencies of all participants (researchers, clinicians
and PLHIV) to converge in the development of interven-
tions. Furthermore, we incorporated the three criteria of
efficacy identified by Rueda and colleagues [15].
There remains only to verify the efficacy of this interven-
tion in optimizing ARV-medication-taking behaviour. To
this end, a randomized was realized. We believe that an
intervention based on a solid theoretical framework
aimed at the acquisition of skills necessary to manage
ARV-medication will foster optimal ARV-treatment taking
behaviour among PLHIV.
Conclusion
This article describes the results of a collective effort by
researchers, clinicians and PLHIV to share their knowl-
edge and create an intervention to promote optimal ARV-
treatment taking. Intervention mapping was used as a
framework for developing the intervention. The goal of
the intervention was the acquisition and mobilization of
skills to manage ARV-medication taking and the enhance-
ment of self-efficacy and positive attitudes towards ARV-
treatment taking, thus foster the desired behaviour.
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